Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Digestion ; 99(2): 172-178, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30179876

RESUMO

AIMS: The influence of lifestyle-related factors, including smoking and drinking, was evaluated for Helicobacter pylori eradication therapy with vonoprazan or proton pump inhibitors (PPIs). METHODS: Between 2012 and 2016, the medical records of 620 patients receiving H. pylori eradication therapy at Saiseikai Karatsu Hospital were evaluated. Patients had received vonoprazan (20 mg) or PPIs with 200 mg clarithromycin and 750 mg amoxicillin twice daily for 7 days. The influence of lifestyle-related factors on eradication failure was determined in the 2 groups. RESULTS: The eradication rates for vonoprazan and lansoprazole, rabeprazole, and esomeprazole were, respectively, 91.0, 73.8, 72.0, and 84.6%. The vonoprazan eradication rate was significantly higher than those for the PPIs (p < 0.01). Habitual smoking and drinking did not increase eradication failure, and smoking and drinking during the eradication period did not reduce the eradication rate. Metabolic syndrome-related factors including obesity, hypertension, and diabetes mellitus had no negative influence on the eradication rate. Eradication with vonoprazan was more effective compared with that achieved through the use of PPIs. CONCLUSION: Lifestyle-related factors including smoking and drinking did not exacerbate the H. pylori eradication failure, and vonoprazan was more effective than the PPIs.


Assuntos
Consumo de Bebidas Alcoólicas/epidemiologia , Antibacterianos/uso terapêutico , Infecções por Helicobacter/tratamento farmacológico , Inibidores da Bomba de Prótons/uso terapêutico , Fumar/epidemiologia , Idoso , Consumo de Bebidas Alcoólicas/efeitos adversos , Amoxicilina/farmacologia , Amoxicilina/uso terapêutico , Antibacterianos/farmacologia , Claritromicina/farmacologia , Claritromicina/uso terapêutico , Quimioterapia Combinada/métodos , Feminino , Infecções por Helicobacter/microbiologia , Helicobacter pylori/efeitos dos fármacos , Helicobacter pylori/isolamento & purificação , Humanos , Masculino , Pessoa de Meia-Idade , Inibidores da Bomba de Prótons/farmacologia , Pirróis/farmacologia , Pirróis/uso terapêutico , Estudos Retrospectivos , Fumar/efeitos adversos , Sulfonamidas/farmacologia , Sulfonamidas/uso terapêutico , Falha de Tratamento
2.
Esophagus ; 15(2): 83-87, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29892932

RESUMO

BACKGROUND: The aim of this study was to evaluate the differences in upper gastrointestinal symptoms between generations and genders in relatively healthy Japanese subjects. METHODS: Altogether, 4086 healthy Japanese male and female (M/F) adults (M/F: 2244/1842) were analyzed. Among them, 3505 subjects (M/F: 1922/1583) were underwent a routine medical checkup at one of five hospitals in Saga, Japan from January 2013 to December 2013. The others were 581 (M/F: 322/259) healthy young volunteers at the Saga Medical School from April 2007 to March 2013. The participants were asked to complete the frequency scale for the symptoms of gastroesophageal reflex disease (FSSG) questionnaire, undergo upper gastrointestinal endoscopy, and submit to a rapid urease test to diagnose Helicobacter pylori infection. Among the 4086 subjects, the 2414 who had no H. pylori infection and no positive endoscopic findings were enrolled in the study. RESULTS: Subjects' average age was 46.9 ± 12.2 years, with males' and females' ages being almost equivalent. The total FSSG score were high in females compared to males (P < 0.01) and decreased significantly with aging (P < 0.05). Among the generations, FSSG scores were the highest for those 20-29 years old, and they were significantly decreased with ageing in both males and females (P < 0.05). CONCLUSION: The FSSG score was significantly higher in healthy Japanese females than in males, and the scores decreased with aging.


Assuntos
Refluxo Gastroesofágico/epidemiologia , Infecções por Helicobacter/epidemiologia , Helicobacter pylori , Avaliação de Sintomas , Adulto , Fatores Etários , Idoso , Testes Respiratórios , Endoscopia Gastrointestinal , Feminino , Refluxo Gastroesofágico/diagnóstico , Voluntários Saudáveis , Infecções por Helicobacter/diagnóstico , Humanos , Japão/epidemiologia , Masculino , Pessoa de Meia-Idade , Fatores Sexuais , Inquéritos e Questionários , Urease/análise , Adulto Jovem
3.
Intern Med ; 56(11): 1447, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28566615
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...